Frequency of patient-provider conversations and patient activation are the 2 most significant predictors of a high-risk patient’s behaviors to prevent kidney disease. Objectives: In the US, an ...
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results